Streetwise Reports Examines Analyst’s View of ‘One of the Most Undervalued Biotech Companies in Canada’ SAN FRANCISCO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- David Kideckel, an analyst with Beacon Securities Ltd., explained the investment thesis for this clinical-stage life sciences firm. Included in this...